Mobilaser Study to Help With People Who Are Having Problems With Their Gait

Early Phase 1CompletedNCT01581645

Mayo Clinic11 enrolled

Overview

Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.

Can patients walk faster and have less freezing when using the mobilaser then when not using it

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Parkinson's Disease Parkinsonism

Interventions

MobilaserDEVICE

Patients will begin by collecting data at home without using the mobilaser. They will then be given the mobilaser to use at home for 6 weeks while they collect data on whether their gait has improved. They will then have to return the Mobilaser to the clinic and collect data at home for 3 days to see if there is a difference.

Eligibility

Sex: ALLMin age: 30 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Parkinsonian patients with Freezing of Gait or Gait hesitation. * Must have evidence of bradykinesia ambulating (stride reduction or reduced arm swing) * Must have a constant caregiver Exclusion Criteria: * No cardiopulmonary contraindications to ambulation, e.g., unstable angina pectoris; * Severe arthritis; * Cerebellar or sensory ataxia; * Recent knee or hip surgery

Locations (1)

Mayo Clinic in Florida

Jacksonville, Florida, United States

Outcomes

Primary Outcomes

Improvement in Gait

Time frame: 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.